Amicus Therapeutics, Inc. (FOLD) Posts Q3 Loss of $0.34/Sh

November 12, 2013 8:32 AM

Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q3 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found